SCHEMBL9334644

SCHEMBL9334644

OCCc1cccnc1CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 6/20 0.39
TKT P29401 2/20 0.37
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CXCR4 P61073 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RIPK1 Q13546 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21618225 0.89 L3MBTL1 (0.50) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL31303512 0.89 L3MBTL1 (0.50) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL18995127 0.89 L3MBTL1 (0.55) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL24701183 0.88 GRM5 (0.42) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL28490737 0.86 L3MBTL1 (0.42) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL10696175 0.82 KDM4E (0.49) ALDH1A1KDM4ENPC1GAARAB9A
SCHEMBL27895802 0.81 ALDH1A1 (0.39) L3MBTL1ALDH1A1HSD17B10KDM4ETKT
SCHEMBL31692108 0.80 KDM4E (0.39) L3MBTL1ALDH1A1KDM4ETKTCYP1A2
SCHEMBL31308700 0.78 ALDH1A1 (0.69) L3MBTL1ALDH1A1HSD17B10KDM4EMAPT
SCHEMBL1431751 0.78 L3MBTL1 (0.42) L3MBTL1ALDH1A1HSD17B10KDM4ETKT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105093874-A Electrophotographic member, process cartridge, and electrophotographic apparatus CANON KK 2015-11-25 CN disclosed
US-20090312306-A1 TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINES AS 5-HT2C LIGANDS CASCADE THERAPEUTICS INC. (CA) 2009-12-17 US disclosed
US-5280096-A Optically active polymer UNIVERSITY OF NEW MEXICO (US) 1994-01-18 US disclosed
US-5166062-A Reaction a mixture of acyl esters with enzymes and selectively deacylating followed by separation UNIVERSITY OF NEW MEXICO (US) 1992-11-24 US disclosed
US-4477673-A Process for the preparation of substituted divinylpyridines and novel substituted divinylpyridines CIBA-GEIGY CORPORATION (US) 1984-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312306-A1 TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINES AS 5-HT2C LIGANDS HTR2C, HTR2A, HTR5A L3MBTL1 3929/4885ALDH1A1 1316/4885HSD17B10 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.